A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions

P.J.D. van Steenwijk, T.H. Ramwadhdoebe, M.J.G. Lowik, C.E. van der Minne, D. Berends-van der Meer, L.M. Fathers, A.R.P.M. Valentijn, J. Oostendorp, G.J. Fleuren, B.W.J. Hellebrekers, M.J.P. Welters, M.I. van Poelgeest, C.J.M. Melief, G.G. Kenter, S.H. van der Burg

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1485-1492
JournalCancer Immunology and Immunotherapy
Volume61
Issue number9
DOIs
Publication statusPublished - 2012

Cite this

van Steenwijk, P. J. D., Ramwadhdoebe, T. H., Lowik, M. J. G., van der Minne, C. E., Berends-van der Meer, D., Fathers, L. M., ... van der Burg, S. H. (2012). A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions. Cancer Immunology and Immunotherapy, 61(9), 1485-1492. https://doi.org/10.1007/s00262-012-1292-7
van Steenwijk, P.J.D. ; Ramwadhdoebe, T.H. ; Lowik, M.J.G. ; van der Minne, C.E. ; Berends-van der Meer, D. ; Fathers, L.M. ; Valentijn, A.R.P.M. ; Oostendorp, J. ; Fleuren, G.J. ; Hellebrekers, B.W.J. ; Welters, M.J.P. ; van Poelgeest, M.I. ; Melief, C.J.M. ; Kenter, G.G. ; van der Burg, S.H. / A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions. In: Cancer Immunology and Immunotherapy. 2012 ; Vol. 61, No. 9. pp. 1485-1492.
@article{2a3e1074a83a4a5baa73e9f7d8115d70,
title = "A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions",
author = "{van Steenwijk}, P.J.D. and T.H. Ramwadhdoebe and M.J.G. Lowik and {van der Minne}, C.E. and {Berends-van der Meer}, D. and L.M. Fathers and A.R.P.M. Valentijn and J. Oostendorp and G.J. Fleuren and B.W.J. Hellebrekers and M.J.P. Welters and {van Poelgeest}, M.I. and C.J.M. Melief and G.G. Kenter and {van der Burg}, S.H.",
year = "2012",
doi = "10.1007/s00262-012-1292-7",
language = "Undefined/Unknown",
volume = "61",
pages = "1485--1492",
journal = "Cancer Immunology and Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "9",

}

van Steenwijk, PJD, Ramwadhdoebe, TH, Lowik, MJG, van der Minne, CE, Berends-van der Meer, D, Fathers, LM, Valentijn, ARPM, Oostendorp, J, Fleuren, GJ, Hellebrekers, BWJ, Welters, MJP, van Poelgeest, MI, Melief, CJM, Kenter, GG & van der Burg, SH 2012, 'A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions' Cancer Immunology and Immunotherapy, vol. 61, no. 9, pp. 1485-1492. https://doi.org/10.1007/s00262-012-1292-7

A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions. / van Steenwijk, P.J.D.; Ramwadhdoebe, T.H.; Lowik, M.J.G.; van der Minne, C.E.; Berends-van der Meer, D.; Fathers, L.M.; Valentijn, A.R.P.M.; Oostendorp, J.; Fleuren, G.J.; Hellebrekers, B.W.J.; Welters, M.J.P.; van Poelgeest, M.I.; Melief, C.J.M.; Kenter, G.G.; van der Burg, S.H.

In: Cancer Immunology and Immunotherapy, Vol. 61, No. 9, 2012, p. 1485-1492.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions

AU - van Steenwijk, P.J.D.

AU - Ramwadhdoebe, T.H.

AU - Lowik, M.J.G.

AU - van der Minne, C.E.

AU - Berends-van der Meer, D.

AU - Fathers, L.M.

AU - Valentijn, A.R.P.M.

AU - Oostendorp, J.

AU - Fleuren, G.J.

AU - Hellebrekers, B.W.J.

AU - Welters, M.J.P.

AU - van Poelgeest, M.I.

AU - Melief, C.J.M.

AU - Kenter, G.G.

AU - van der Burg, S.H.

PY - 2012

Y1 - 2012

U2 - 10.1007/s00262-012-1292-7

DO - 10.1007/s00262-012-1292-7

M3 - Article

VL - 61

SP - 1485

EP - 1492

JO - Cancer Immunology and Immunotherapy

JF - Cancer Immunology and Immunotherapy

SN - 0340-7004

IS - 9

ER -